For the year ending 2025-12-31, CYTK made $88.039M in revenue. -$786.723M in net income. Net profit margin of -893.61%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Total revenues | 88.039 | 15 | ||
| Research and development | 416.026 | 339.408 | ||
| General and administrative | 284.271 | 215.314 | ||
| Total operating expenses | 700.297 | 554.722 | ||
| Operating loss | -612.258 | -536.248 | ||
| Interest expense | 45.579 | 37.701 | ||
| Non-cash interest expense on liabilities related to revenue participation right purchase agreements | 58.289 | 48.811 | ||
| Interest and other income, net | 48.42 | 51.534 | ||
| Change in fair value of derivative liabilities | 4.2 | 1.3 | ||
| Change in fair value of liabilities related to rpi transactions | -0.2 | -19.6 | ||
| Debt conversion expense | 121.249 | - | ||
| Net loss | -784.955 | -589.526 | ||
| Unrealized (loss) gain on available-for-sale securities, net | -0.99 | 2.153 | ||
| Foreign currency translation adjustments | -0.778 | 0.255 | ||
| Comprehensive loss | -786.723 | -587.118 | ||
| Basic EPS | -6.54 | -5.26 | ||
| Diluted EPS | -6.54 | -5.26 | ||
| Basic Average Shares | 120,103 | 111,979 | ||
| Diluted Average Shares | 120,103 | 111,979 | ||
CYTOKINETICS INC (CYTK)
CYTOKINETICS INC (CYTK)